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Abstract		37	
	38	
Context		39	
Congenital	adrenal	hyperplasia	(CAH),	CYP21A2	deficiency,	results	in	cortisol	and	aldosterone	40	
deficiency	and	increased	production	of	androgens,	with	a	good	genotype	phenotype	correlation.		41	
Objective		42	
To	study	psychosocial	outcomes	in relation to clinical severity, CYP21A2 genotype, in men and 43	
women.	44	
Design	45	
An	epidemiological	study	with	a	matched	cohort	control	design.	46	
Setting	47	
All	known	CAH	patients	in	Sweden.	48	
Participants		49	
588	patients,	>95%	with	known	severity	of	CAH;	100	controls	per	patient	matched	for	sex,	year	50	
and	place	of	birth.		51	
Main	outcome	and	measures 52	
Proxies	for	quality	of	life	were	selected:	level	of	education,	employment,	income,	sick‐leave,	53	
disability	pension,	marriage	and	children		54	
Results	55	
Women with salt-wasting (SW) CAH had completed primary education less often (OR 0.3), not	56	
explained	by	neonatal	salt‐crisis	or	hypoglycemia	since	the	men	did	not	differ	from	controls.	57	
Men	and	women	in	the	less	severe	I172N	genotype	group	were	more	likely	to	have	an	academic	58	
education	(OR	1.8)	SW	women	were	more	likely	to	have	an	income	in	the	top	20	percentile	(OR	59	
2.0	).	Both men and women had more disability pension (OR 1.5) and sick leave (OR 1.7). The	men	60	
more	often	had	long	lasting	employment	(OR	3.1).	Men	were	more	often	(OR	1.6)	while	women	61	
were	less	often	married	(OR	0.7).	Patients	had	children	less	often	(OR	0.3).	62	
	 	63	
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Conclusions	64	
This	study	shows	important	outcome	differences	regarding	education,	employment,	marriage	65	
and	fertility	depending	on	sex	and	severity	of	CAH.	The	mechanisms	behind	this	and	the	66	
increased	risk	for	sick	leave	or	disability	pension	in	both	men	and	women	should	be	identified	to	67	
improve	medical	and	psychological	care. 68	
  69	
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Background 70	
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency results in varying degrees of 71	
cortisol and aldosterone deficiency and at the same time increased androgen production. The clinical 72	
presentation of classical CAH ranges from the severe salt-wasting (SW) form with risk of developing 73	
hypoglycemia and adrenal salt crisis, which may be lethal, to simple virilizing (SV) form in which the 74	
synthesis of aldosterone is less impaired. The androgen excess, present already in utero, results in 75	
varying degrees of prenatal virilization of the external genitalia in 46,XX individuals, which can result 76	
in uncertainty of sex assignment at birth. CAH is included in the neonatal screening in several 77	
countries (1).The Swedish screening program for CAH was started in 1986. The incidence is reported 78	
to be 1 in 15000 live births in most populations and 1 in 9000 in Sweden (2). 79	
In the milder non-classical (NC) form there is no prenatal virilization and the patients may come to 80	
diagnosis due to signs of increased androgen production such as growth acceleration or 81	
pseudopubertas precox in childhood and infertility or hirsutism in adults (3,4).   82	
 83	
Medical treatment consists of glucocorticoid and mineralocorticoid substitution with the aim to 84	
decrease ACTH and thereby the adrenal androgen production (5). The balance between over-85	
treatment, with the risk of developing obesity, and under-treatment, resulting in increased androgen 86	
production is often difficult. Both over- and under-treatment result in a compromised final height. In 87	
the long term, over-substitution with glucocorticoids can lead to secondary complications in adulthood 88	
as obesity, increased cardiovascular risk, and decreased bone mineral density (3).  89	
The deficit in endogenous cortisol production affects systems vital for stress and glucose regulation in 90	
the body. Endogenous cortisol production is necessary for normal adreno-medullary differentiation 91	
and epinephrine synthesis. In CAH the reduction in epinephrine levels correlates with the severity of 92	
the disease (4,6)  In addition, glucocorticoid replacement cannot mimic endogenous cortisol release 93	
completely. A recent study also point to the importance of evaluating type of glucocorticoid treatment 94	
as this can influence quality of life (7).  95	
Traditionally, genital surgery in virilised females has been performed early in life. However, the 96	
surgical outcome has not been altogether satisfactory, even when using modern techniques. There is an 97	
ongoing debate about optimal timing and indications for feminizing surgery (8-10) 98	
Studies on patients with CAH have taught us much of what is known today about the effects of 99	
androgen on brain development and behavior. Several aspects of gender related behavior such as toy 100	
play (11), activity level (12), playmate preference (13), career choice (14) and sexual orientation (15) 101	
have been shown to be related to the severity of CAH, i.e. to the degree of prenatal androgen exposure 102	
(16).    103	
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Quality of life and psychological outcome studies on CAH have yielded conflicting results. General 104	
psychosocial adaptation, as compared to siblings, was not found to differ (17), while the self-reported 105	
health-related quality of life has been reported to be negatively affected, particularly in women (18-106	
21).  Sexual functioning was reported to be impaired (22-24) and women with CAH were reported 107	
more often to be living alone (14)  while this has not been reported in males (3)  108	
 109	
Fertility is generally reported to be impaired in both women and men with CAH, (18,23,25) but 110	
pregnancy rates were reported to be normal for those who seek medical attention (26,27) and most 111	
males seeking medical attention seem to succeed in fathering a child eventually (25). 112	
 113	
There is a good genotype-phenotype correlation (28,29). In a Swedish follow-up study women in the 114	
null genotype group were considerably more affected by the disease, also compared to the I2 splice 115	
genotype group (8,14). However, the patient’s perception of how the disease had affected relationships 116	
with relatives and close friends did not correlate with disease severity, indicating that coping strategies 117	
are important.(30)  118	
 119	
Sweden is an exceptionally suitable country for epidemiological studies with several nationwide 120	
population based registers. A national CAH registry was recently created (2) enabling epidemiological 121	
studies on this nonbiased unselected national cohort of patients. The aim of the present study was to 122	
investigate psychosocial factors that can be interpreted as proxies for quality of life in relation to the 123	
CYP21A2 genotype or clinical severity, in both men and women. 124	
 125	
Methods  126	
All patients with confirmed CYP21A2 deficiency born 1910 to 2009, included in a national CAH 127	
registry at the Swedish screening laboratory (2) were included in the study. The CAH registry 128	
originally comprised 572 patients, born before January 2010. However, 12 patients could not be 129	
included due to incomplete personal identification number, 13 cases were not identified in the 130	
epidemiological data-base, and in two cases the personal identification number had been re-used. 131	
Thus, in total 545 patients were included from the registry. An additional 748 patients had been given 132	
the diagnosis of CAH (ICD-8: 255.01, 255.08, ICD-9: 2552, 255C, and ICD-10: E25.0) in the national 133	
patient register at least once. From the latter cohort 180 patients with a CAH diagnosis on more than 134	
two occasions were further scrutinized. Those who had subsequently been given other diagnoses, i.e. 135	
Addison’s disease, Cushings syndrome, acromegaly, or had received glucocorticoid treatment due to 136	
malignancies, were excluded. The remaining 43 patients, identified via the diagnosis registry and with 137	
a possible diagnosis of CAH, were included as a separate group in the study. Hence, the national CAH 138	
registry comprised more than 90% of the diagnosed patients in the country.  139	
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The final sample thus consisted of 588 patients with CAH. For some statistical analyses, only patients 140	
born 1925-1991 were assessed, as the younger ones would not be eligible for the measures studied.  141	
 142	
Sub-classification of patients 143	
Patients with a known CYP21A2 genotype were classified into genotype groups depending on the 144	
severity of the mildest allele (31). In addition, patients were given a clinical classification. The null 145	
and I2 splice genotype groups were included in the SW group, and the I172N and P30L genotype 146	
groups in the SV group. Patients with genetically verified (V281L, or P453S genotype) or clinically 147	
diagnosed NC CAH were labelled the NC group. Patients for whom no mutation analysis had been 148	
performed, were given a clinical classification, SW, SV, or NC if the clinical presentation was known 149	
by the authors (AN or HF). Patients with an unknown severity were designated as unknown (NA) 150	
(Table 1).  151	
 152	
 153	
The CYP21A2 genotype was known in more than 85% of the patients (Table 1). There were more 154	
women than men in the cohort but the age distribution was approximately similar. The age distribution 155	
is shown in table 2. For each patient 100 controls from the general population were matched for sex 156	
and the year and place of birth. When the patient had immigrated to Sweden controls were matched for 157	
this factor as well.  158	
 159	
All patients’ and controls’ identities were coded before they were linked to several longitudinal 160	
nationwide population-based registries in Sweden: the National Patient Register (maintained by the 161	
National Board of Health and Welfare) which contains discharge diagnoses based on the international 162	
classification of diagnoses (ICD) of inpatient care, with partial coverage since 1964 and complete 163	
coverage since 1987 and outpatient care since 2001. The Multi-Generation Register (Statistics 164	
Sweden) contains information about relationships between people born after 1932, registered 165	
nationally after 1961, and their parents/adoptive parents; the Migration Records (Statistics Sweden) 166	
comprise registered migrations since 1901; the Longitudinal Integrated Database for health insurance 167	
and labour market studies (LISA) comprises data on income, education, occupation, employment 168	
status, social transfers, etc. from 1990 to 2009; the Register of Education (Statistics Sweden) holds 169	
information about education for the years 1985–1989.  170	
 171	
 172	
Measures 173	
The proportion of individuals who were eligible for secondary education was assessed as an indication 174	
of school achievement. It was possible to obtain this information for persons born between 1982-1991. 175	
For the rest of the measures patients born during 1925–1991 could be included (LISA). Employment 176	
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was assessed by two parameters: employment during 3–7 years or more than 7 years. Disposable 177	
income based on family income comprises the total earned income and allowances for the period 178	
1990-2009 (LISA). For each year, the 20th percentile of the income in the population was calculated. 179	
The individuals were then divided into groups depending on income < 20%, 20-80%, and > 80% 180	
percentiles. The odds ratio (OR) was calculated for the risk of falling into the lowest or highest income 181	
categories. The frequency of periods with sick leaves longer than 14 consecutive days for more than 182	
two years was investigated (LISA). The information on disability pension, was available from 1990 to 183	
2004 (LISA). Social welfare support was defined as anyone in the family having received this 184	
financial support during more than one year (LISA). Marriage indicates the first registered marriage or 185	
partnership for this and .the number of biological children in the Multi-Generation Registry was used. 186	
 187	
The study was approved by the Ethics Committee Karolinska Institutet.  188	
 189	
Statistics 190	
A matched cohort design was used to equalize the time at risk in the patient and the controls. Risks 191	
were estimated using Conditional regression analyses and Cox regression. ORs were calculated with 192	
95% confidence intervals (CIs). OR with a confidence interval not surpassing 1.0 was considered 193	
significant. Calculations were performed using SAS version 9.3 (Statistical Analyses Systems). 194	
 195	
Results 196	
The proportion of patients born in Sweden differed between genotype groups. In the NC group and the 197	
P30L genotype group 84% and 75% respectively had been born in Sweden while 95% of the patients 198	
in the null, I2 splice and I172N genotype groups were born in Sweden. Table 3 describes the results 199	
below in detail. The table with all results for the different genotype groups can be found in the 200	
supplement.  201	
 202	
Education 203	
Women with CAH had completed primary education less often than controls (OR 0.3 [0.2–0.6]). This 204	
was significant for women with SW CAH (OR 0.3 [0.1-0.7]) but was not observed in SW men (OR 205	
1.2 [0.3–4.6]). The same trend was seen in SV (OR 0.3 [0.1-1.1]) and NC women and men (OR 0.5 206	
[0.1-1.9]) but not in men with known severity.  207	
With regard to the level of education achieved the trend was toward the SW group more often having 208	
primary education as the highest level attained. Primary education as the highest level of education 209	
achieved was noted more often for women in the null genotype group (OR 3.2 [1.1–9.5]). The SV 210	
group more often had an academic education than controls (OR 1.5 [1.0-2.3]). This held true for men 211	
and women in the I172N genotype group (OR 1.8 [1.1–2.8]). The trend was in the same direction also 212	
for the NC groups.  213	
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 214	
Employment  215	
Men with CAH were more likely to have been employed for more than 7 years (OR, 3.1 [1.1–8.8]).  216	
Patients in the NC group tended to more often be employed during 3-7 years (OR 7.6 [1.5–37.4)]. In 217	
all other instances, the patients and controls did not differ significantly. 218	
 219	
Income 220	
Disposable family income did not show significant differences for any of the groups except for SW 221	
women that were more likely to be in the top 20th percentile compared to controls.  222	
 223	
Sick leave and disability pension  224	
Patients with CAH more often had disability pension (OR 1.5 [1.0-2.2]) and were more often on sick 225	
leave than controls (OR 1.7 [1.2–2.4]). In the SW patients this was not significant; but this group more 226	
often had disability pension (OR 2.0 [1.0–3.9]). However, men in the null genotype group had periods 227	
of sick leave more often (OR 4.8 [1.1–21.1]). Men and women with SV CAH had been on sick leave  228	
more often than controls (men and women OR 2.8 [1.5–5.4]; men OR 3.5 [1.3–9.4]; women OR 2.6 229	
[1.1–6.4]) but did not have disability pension more often. Men and women with I172N genotype were 230	
more likely to have been on sick leave (OR 4.9 [2.2–11.2]). On the contrary, among NC patients, the 231	
risk of being on sick leave was lower than for the controls (OR 0.3 [0.1–0.7]). However, the NC group 232	
received disability pension more often (OR 3.3 [1.0-11.1]).  233	
 234	
Social welfare 235	
The probability of having received social welfare was not significantly increased except for among 236	
women with the NC form (OR 2.4 [1.0–6.2]).  237	
 238	
Marriage 239	
As a group, patients were married to the same extent as controls, however, men were more likely to be 240	
married compared to controls (OR 1.6 [1.0-2.5]). Women with SW CAH were married less often (OR 241	
0.5 [0.2-1.1]). This was significant for women in the I2 splice genotype group (OR 0.3 [0.1–0.9]). 242	
There were a total of 6 partnerships registered among women with CAH and 25 in the 100 times larger 243	
control group.  244	
 245	
Children 246	
Patients with CAH were less likely to have biological children than controls (OR 0.3 [0.2–0.3]). All 247	
SW and SV, women and men, had significantly less often children (SW OR 0.1 [0.1–0.2]; SV OR 0.4 248	
[0.2–0.7]). When assessing the genotype groups, this was significant for women with null mutations 249	
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OR 0.0 [0.0-0.2] both women and men with I2 splice mutations (OR 0.1 [0.1-0.3]), and in the I172N 250	
group (OR 0.4 [0.2–0.8]). 251	
 252	
 253	
Discussion 254	
This is the largest population-based epidemiologic study on psychosocial outcome conducted in CAH 255	
patients with a clinically or genetically verified diagnosis of 21-hydroxylase deficiency. Molecular 256	
genetics were available for more than 80% of the patients. It is also unique that the registry covered 257	
more than 90% of the total CAH population identified in the country. We investigated parameters that 258	
captures psychosocial aspects of daily life and may reflect the prerequisites for a good quality of life: 259	
having a partner, being able to work and support oneself, staying healthy and independent, and for 260	
some, the possibility of having children. The total cohort of CAH patients did not differ greatly from 261	
the general population in a number of the parameters investigated. However, using sex, the clinical 262	
classification (SW, SV, NC) and the CYP21A2 genotype enabled us to identify important differences 263	
and difficulties within the patient population that would not have become evident otherwise. 264	
 265	
There were some unexpected findings regarding education. We saw that the risk of not completing the 266	
primary education curriculum was increased for girls/women particularly in the SW group, while this 267	
was not the case for boys. There are multiple possible reasons for failing to achieve in school. One 268	
could be cognitive deficits or learning difficulties. In patients with CAH, hypoglycaemia together with 269	
salt-crisis, has been suggested to be one reason for the weaker cognitive performance seen in the null 270	
genotype group (32). In addition, overtreatment with high levels of hydrocortisone has been shown to 271	
affect cognitive functions such as memory (33). The risk was increased also in assessments for women 272	
with SV forms of CAH, but not for men in any of the groups. It is therefore unlikely that 273	
hypoglycemia and salt-crisis, which would have been more common among the boys before the 274	
screening results were available, is the explanation for this difference. It is possible that women 275	
receive higher doses of hydrocortisone in order to prevent the effects of excess androgens, possibly 276	
affecting cognitive functions negatively. A more likely explanation is that the results reflect 277	
psychological and social problems that the girls might encounter during the school years due to the 278	
effects of prenatal androgen exposure, which may affect their adjustment and relations to peers. 279	
Additive effects of various risk factors, such as vulnerability to stress, are possible and underline the 280	
importance of coping and the accessibility to psychological support during these critical teenage years 281	
and as young adults. Further studies are needed to investigate and identify such risk factors in order to 282	
improve preventive care and support. 283	
 284	
The level of education has been assessed in some previous studies. Both a higher and lower percentage 285	
of patients had a superior educational level compared to controls depending on the Prader stage 286	
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(20,23) and no statistical differences were found compared to the general population (21). Our results 287	
indicate higher levels of education in the SV and NC groups. However, increased probability of not 288	
finishing primary education was also observed for women in several of the severity groups. This 289	
suggests that there may be subgroups of patients, with or without a completed education. Employment 290	
was not significantly lower for women in the null genotype group, even though some of them did not 291	
finish primary school. This implies that a negative impact of having a disease such as CAH can be 292	
present at different times during the life span, but it does not have to be permanent. 293	
 294	
The patients with CAH were more often on sick leave and more likely to receive disability pension. 295	
We interpret this as being two aspects of the same negative effect of the disease. A decreased 296	
biological ability to cope with stress and stressful situations may contribute to the increase in sick 297	
leave and disability pension. Further studies are needed to properly assess the mechanisms behind this 298	
increase. Contrary to the findings in Norway (20) we did not detect any significant economic 299	
differences between the patient groups. However, an interesting finding was the increased likelihood 300	
of women in the SW group to be in the top 20th percentile income group, compared to controls. This 301	
could possibly be explained by the choice of more male dominated occupations (14) with a higher 302	
average income level. It can also indicate that there are subgroups of patients that succeed in finishing 303	
school and then fare well, or that some patients due to the acquirement of coping strategies are able to 304	
deal better with their situation as they grow older. This further underlines the importance of 305	
psychological support. 306	
 307	
Women in the SW groups were less often married. The rest of the women did not differ significantly 308	
from controls. Men were more often married than controls, the reason for this is unknown. Both men 309	
and women with classical CAH (SW and SV forms) had fewer biological children than their controls, 310	
confirming previous findings. Earlier research has reported both decreased fertility (23,26,27) and a 311	
reduced interest in infants (34) among women with CAH. The proportion of female patients who were 312	
married was lower, although the difference expressed as OR for being married, differed less than the 313	
likelihood that women with classical CAH would have children, suggesting decreased fertility. The 314	
higher proportion of women with CAH with homosexual orientation, especially in the more severe 315	
genotype groups (15) may be a contributing factor. 316	
Fertility in men has also been reported to be impaired (25,35). Our data show that even though more 317	
men than women with CAH had children, the frequency was considerably lower than in the general 318	
population. Further studies are needed to properly assess the reasons behind the fact that patients with 319	
CAH are less likely to have children despite living in stable relationships.  320	
 321	
Both men and women differed from controls in several of the measures studied. Women were in some 322	
respects more affected by the disease, especially the more severe forms of the disease. However, also 323	
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women in the NC group seemed to have more difficulties than the controls. They did not finish school 324	
to the same extent and they more often received disability pension and social welfare support. This 325	
group differs from the other patients in that they were most often diagnosed late, due to symptoms and 326	
signs of androgen excess, as opposed to being diagnosed in the neonatal period either clinically or 327	
through screening. Hence, they may be more affected by the disease and have attracted medical 328	
attention later on the basis of their own perceptions of the androgen symptoms, and possibly therefore 329	
psychologically affected. 330	
 331	
There are limitations with this study related to the time periods that the available registers in Sweden 332	
cover. The Diagnosis Registry was started in 1964 but it did not have complete coverage until 1987. 333	
The pharmaceutical registry has been in place since 2005, and does not cover drugs prescribed on 334	
license, which includes hydrocortisone preparations in Sweden. Aspects of treatment could therefore 335	
not be assessed. The school performance variables are available for patients born after 1982 due to 336	
changes in the school system and the registries. The LISA registry, where much of the data is collected 337	
started in 1990, and can therefore include patients alive at some point during this period. It would be 338	
interesting to perform analyses to compare the group identified by screening and those who were not, 339	
or make comparisons for patients born before and after treatment became available in the 1950. For 340	
most outcomes however, this was not meaningful due to paucity of data from either the older or 341	
younger patients in the registries. The large differences in survival rate during different time periods as 342	
reported in a previous publication (Gidlöf et al 2013), adds to these difficulties by making the number 343	
of patients exceedingly small during earlier years. 344	
 345	
Conclusion 346	
This large epidemiological study on a nonbiased national cohort of patients with known severity of 347	
CAH showed that the patients differed significantly from the matched controls on a number of 348	
parameters that can be interpreted as indicators of quality of life.  Patients with the severe forms were 349	
more affected by the disease, and women were more affected than men, especially regarding education 350	
and fertility aspects. Despite the increased risk for women with SW CAH not to finish primary school 351	
they were more likely to have a high income. All patients and particularly the men were more often on 352	
sickleave than controls. Both men and women were more likely to have disability pension. Further 353	
studies to identify the underlying explanations for these findings are important to improve the future 354	
care of these patients in terms of medical as well as psychological care from an early age. 355	
 356	
 357	
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Legends to tables 464	
 465	
Table 1 466	
 467	
Sub-classification of patients into clinical severity and CYP21A2 genotype groups. 468	
 469	
*including genotype groups P482S and P453S and clinically diagnosed NC 470	
 471	
 472	
Table 2 473	
 474	
Age distribution of the patients in the different CYP21A2 genotype groups, males and females. 475	
 476	
Table 3 477	
Odds ratios (OR) for all the studied measures, assessed for the whole cohort of patients, women and 478	
men, and the clinical severity groups. OR with 95% confidence interval in parenthesis is given. 479	
Significant differences in bold caracters. 480	
 481	
Table 4 482	
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Odds ratios for the measures studied, for women and men in all the different subgroups; CYP21A2 483	
genotype groups, not classified (NA) and epid (patients identified through national patient registry). 484	
*Denotes that odds ratio was not possible to calculate 485	
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Tables 487	
 488	
Table 1 
	489	
Clinical	group	 genotype	 male female	
SW	 	 240 105 135	
	 Null 41 59	
	 clin	SW	 9 9	
	 I2	splice	 55 67	
SV	 	 167 76 91	
	 I172N	 58 72	
	 clinSV	 6 7	
	 P30 12 12	
NC	 	 75 19 56	
	 V281L	
NC*	
14
5	
42	
14	
unknown	 	 106 53 53	
	 NA 39 24	
	 Epid	 14 29	
Total	 	 588 253 335	
	490	
 491	
 492	
Table 2 493	
 494	
 495	
 total Null Clin 
SW 
I2splice I172N Clin 
SV 
P30 NC NA epid 
Males 253          
1921-1960 27 1 2 3 14 3 0 0 2 2 
	 17
1961-1991 130 20 6 26 22 3 5 10 30 9 
1991-2009 96 20 1 26 22 0 7 9 8 3 
Females 335          
1911-1960 37 0 0 4 11 0 0 9 1 12 
1961-1990 188 30 7 36 41 6 9 29 19 11 
1991-2010 110 29 2 27 20 1 3 18 4 6 
	496	
 497	
 498	
 499	
 500	
 501	
Table 3 502	
	503	
all born 1982-91 All patients All women  All men 
complete education  0.5 (0.3-0.9) 0.3 (0.2-0.6) 0.9 (0.4-2.1) 
all born 1925-1991 
primary education (10 yr)  0.8 (0.6-1.1) 0.8 (0.5-1.4) 0.8 (0.5-1.3) 
higher education 0.7 (0.4-1.2) 0.9 (0.4-1.7) 0.5 (0.2-1.3) 
working 3-7 years 1.3 (0.7-2.2) 1.4 (0.7-2.8) 1.3 (0.5-3.6) 
working >7 years 1.8 (0.992-3.2) 1.6 (0.8-3.2) 3.1 (1.1-8.8) 
highincome 0.9 (0.7-1.2) 0.9 (0.7-1.2) 0.8 (0.6-1.2) 
lowincome 0.9 (0.6-1.4) 0.8 (0.5-1.4) 1.0 (0.5-2.0) 
sickleave 1.7 (1.2-2.4) 1.3 (0.8-2.0) 2.8 (1.6-4.8) 
disability pension 1.5 (1.0-2.2) 1.4 (0.9-2.4) 1.6 (0.8-3.2) 
social wellfare 1.0 (0.7-1.4) 1.1 (0.7-1.7) 0.9 (0.5-1.6) 
marriage 1.0 (0.8-1.4) 0.7 (0.5-1.0) 1.6 (1.0-2.5) 
children 0.3 (0.2-0.3) 0.2 (0.1-0.3) 0.4 (0.2-0.6) 
 504	
 505	
Table 4 506	
 507	
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 508	
 SW women SW men SW together SV women SV men SV together NC women NC men NC together 
complete 
education 0.3(0.1-0.7) 1.2(0.3-4.6) 1.4(0.4-5.2) 0.3(0.1-1.1) 1.0(0.2-4.9) 0.6(0.2-1.5) 0.5(0.1-2.5) 0.5(0.0-6.0) 0.5(0.1-1.9) 
born 1982-
94 n 80 61 140 69 49 118 38 10 38 
primary 
education 
(10 yr) 1.4(0.7-2.9) 1.2(0.5-2.5) 1.3(0.8-2.2) 0.5(0.1-1.6) 0.5(0.2-1.5) 0.5(0.2-1.1) 0.4(0.1-1.9) 1.9(0.2-19.5) 0.6(0.3-1.2) 
higher 
education 0.7(0.4-1.1) 0.9(0.5-1.7) 0.7(0.5-1.1) 1.4(0.8-2.4) 1.7(0.9-3.4) 1.5(1.0-2.3) 1.9(0.8-4.1) 1.7(0.4-7.7) 1.8(0.9-3.5) 
working 3-
7 years 0.7(0.2-2.6) 1.4(0.3-6.7) 0.9(0.3-2.5) 1.7(0.4-7.5) 1.7(0.2-15.2) 1.5(0.5-5.0) 6.5(1.2-35.1) >999.999 7.6(1.5-37.4) 
working 
>7 years 2.0(0.6-6.7) 2.9(0.6-13.6) 2.3(0.9-5.8) 1.0(0.2-4.7) 7.3(0.7-79.8) 1.5(0.4-5.3) 3.5(0.6-20.8) >999.999 4.5(0.8-25.4) 
highincom
e 2.0(1.0-4.2) 1.0(0.5-1.9) 0.9(0.5-1.4) 1.0(0.6-2.0) 0.5(0.2-1.0) 1.3(0.7-2.2) 2.0(0.8-5.3) 2.7(0.3-23) 2.1(0.9-4.9) 
lowincome 1.2(0.5-3.1) 0.5(0.1-1.9) 0.9(0.4-1.9) 0.6(0.1-2.7) 0.3(0.0-2.9) 0.5(0.1-1.7) 1.3(0.4-4.4) >999.999 1.0(0.9-5.0) 
sickleave 1.6(0.9-3.0) 1.7(0.7-4.4) 1.6(0.9-3.0) 2.6(1.1-6.4) 3.4(1.3-9.4) 2.8(1.4-5.4) 0.3(0.1-1.1) 0.5(0.1-8.5) 0.3(0.1-0.7) 
disability 
pension 1.7(0.7-4.0) 2.2(0.7-6.9) 2.0(1.0-3.9) 0.9(0.3-2.6) 0.9(0.2-3.5) 0.8(0.4-1.9) 3.4(0.9-11.8) <0.001 3.3(1.0-11.1) 
social 
wellfare 0.6(0.3-1.4) 1.1(0.4-2.6) 0.8(0.4-1.4) 0.7(0.3-1.8) 0.7(0.2-3) 0.7(0.3-1.5) 2.4(1.0-6.2) 1.2(0.1-10.8) 2.0(0.9-4.9) 
marriage 0.5(0.2-1.1) 1.6(0.7-3.5) 0.9(0.5-1.5) 1.1(0.6-2.2) 1.8(0.8-4.4) 1.4(0.8-2.3) 1.4(0.5-3.9) 3.9(0.5-32.7) 1.7(0.7-4.3) 
children 0.05(0.0-0.1) 0.4(0.2-0.8) 0.1(0.1-0.2) 0.4(0.2-0.7) 0.3(0.2-0.8) 0.4(0.2-0.7) 0.9(0.3-2.7) 0.9(0.1-7.1) 0.9(0.3-2.4) 
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